Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00250081 · ClinicalTrials.gov registry record · NA
Comparison of Tendon Transfer, Botox Injections and Ongoing Treatment in Hemiplegic Cerebral Palsy
A NA study, sponsored by Shriners Hospitals for Children.
- Terminated
- Registry status
- NA
- Development phase
- 38
- Enrollment target
NCT00250081: Clinical Trial NA study, sponsored by Shriners Hospitals for Children.
NCT00250081 is a NA study that was terminated before completion, run by Shriners Hospitals for Children. The registered enrollment target is 38 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00250081, a NA study, was terminated before completion, sponsored by Shriners Hospitals for Children.
- TERMINATED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
Study Summary
Doctors use different treatments for people with Cerebral Palsy. Surgery is one option. Botulinum toxin injections are another option; these are given directly into spastic muscles to weaken them temporarily. Regular ongoing treatment (splinting, stretching and exercises) is another option. The investigators want to find out if surgery works better than Botulinum Toxin (Botox) injections or regular ongoing treatment (therapy), and if the effects of Botulinum Toxin injections last for longer than six months.
Interventions
- PROCEDURE Upper Extremity Tendon transfer
- PROCEDURE Botulinum Toxin injections in Upper Extremity
- PROCEDURE Regularly ongoing therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2005-02 |
| Est. Completion | 2013-05 |
| Phase | NA |
Why NCT00250081 stopped before completion
NCT00250081 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 3 interventions - of which Upper Extremity Tendon transfer is the first listed.
NCT00250081 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00250081 about?
NCT00250081 is a clinical study titled "Comparison of Tendon Transfer, Botox Injections and Ongoing Treatment in Hemiplegic Cerebral Palsy". Doctors use different treatments for people with Cerebral Palsy. Surgery is one option. Botulinum toxin injections are another option; these are given directly into spastic muscles to weaken them temporarily. Regular ongoing treatment (splinting, stretching and exercises) is another option. The inve...
What is the current status of trial NCT00250081?
This trial is currently terminated. It is a NA study. The enrollment target is 38 participants. The study started on 2005-02. Estimated completion is 2013-05.
What interventions are being tested in trial NCT00250081?
The interventions under investigation include: Upper Extremity Tendon transfer (PROCEDURE), Botulinum Toxin injections in Upper Extremity (PROCEDURE), Regularly ongoing therapy (PROCEDURE).
Who is sponsoring clinical trial NCT00250081?
This trial is sponsored by Shriners Hospitals for Children, which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00250081's enrollment target sits among peer trials
38 1538th of 2000 higher than 461 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia